What are the guidelines for dose adjustment and monitoring of patients receiving RCHOP with comorbid conditions requiring antidepressant therapy?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18237139
Cited by: 0

Abstract

Currently, no specific evidence-based guidelines exist to adjust R-CHOP dosing in patients needing antidepressants; clinicians should monitor for interactions and adjust treatment as needed.

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment Neutropenia and Cancer Infections Chronic Lymphocytic Leukemia Research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
13 January 2026